JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Risk Analysis of Factors for Metabolic Diseases according to the Epicaridal Adipose Tissue Thickness - which Focused on the Presented Subjects with Asymptomatic Screening Purposes
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Risk Analysis of Factors for Metabolic Diseases according to the Epicaridal Adipose Tissue Thickness - which Focused on the Presented Subjects with Asymptomatic Screening Purposes
Kim, Sun-Hwa; Kim, Jung-Hoon; Kim, Changsoo;
  PDF(new window)
 Abstract
Epicardial adipose tissue(EAT) is metabolically active endocrine organ that secretes several hormones in fat thickness is a risk factor for cardiovascular disease and metabolic disorders. This study was to measure and then using ultrasound epicardial adipose tissue thickness, abdominal subcutaneous fat thickness in the target group correlates and general blood properties and characteristics, and presents a local thickness for prediction of metabolic disorders. Results epicardal adipose tissue of the average thickness measured in each of the subjects was 8.890mm, 4.783mm, 4.777, 6.147mm in each section. Showed the epicardial adipose tissue in correlation with the average thickness of the risk factors age, BMI, SBP, LDH, LDL, TC is a positive correlation relationship(p<0.05) in each section. In particular, the thickness of the metabolic disorders epicardial adipose tissue thickness, abdominal subcutaneous compared to subjects that do not have the risk subjects with a risk factor for fat significantly higher(p<0.05). It showed the most reliable that can be cut-off value of 8.950mm obtained with 66.7 % sensitivity and 80 % specificity for predicting the risk of metabolic disorders.
 Keywords
Epicardial Adipose Tissue Thickness;Metabolic Disorders;
 Language
Korean
 Cited by
 References
1.
Hikmet Yorgun, Ugur Canpolat, Tuncay Hazirolan, Ahmet Hakan Ates, Hamza Sunman, Muhammet Dural, Levent Sahiner, Ergun Baris, Kaya, Kudret Aytemir, Lale Tokgoglu, Giray Kabakci, and Ali Oto, "Increased epicardial fat tissue is a marker of metabolic syndorme in adult patients," international journal of cardiology, Vol.165, No.2013, pp.308-313, 2011.

2.
P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel, "Overweight and obesity as determinants of cardiovascular risk: the Framinham experience," Arch Intern Med, Vol.162, pp.1867-1872, 2002. crossref(new window)

3.
J. B. Albu, A. J. Kovera, and J. A. Johnson, "Fat distribution and health in obesity," Ann N Y Acad Sci, Vol.904, pp.491-501, 2000.

4.
J. E. Manson, W. C. Willett, M. J. Stampfer, G. A. Colditz, D. J. Hunter, S. E. Hankinson, C. H. Hennekens, and F. E. Speizer, "Body weight and mortality among women," N Engl J Med, Vol.333, pp.677-685, 1995. crossref(new window)

5.
L. Lapidus, C. Bengtsson, B. Larsson, K. Pennert, E. Rybo, and L. Sjostrom, "Distribution of adipose tissue and risk of cardiovascular disease and dealth; a 12year follow up of participants in the population study of women in Gothenburg," Sweden. Br Med J, Vol.289, pp.1257-1261, 1984. crossref(new window)

6.
S. H. Baik, S. G. Ahn, and J. H. Choi, "The Relationship of epicardial adipose tissue to metabolic syndrome and cardiovascular risk factors," Department of Cardiology, Vol.72, No.3, pp.290-297, 2007.

7.
M. K. Kim, "Tissue Specific-Metabolism of Lipids for Ectopic Deposition," Journal of Korean Society for the study of obesity, Vol.20, No.3, pp.99-106, 2011. crossref(new window)

8.
J. S. Kim, Usefulness of Abdominal Visceral Fat thickness using Ultrasonography as a predictor of Metabolic Syndrome and Atherosclerosis in OBese Adults, Department of Medicine Graduate School, Kyungpook National University, Daegu, Korea, 2006.

9.
P. Iozzo, "myocardial, perivascular, and epicardial fat," Diabetes Care Suppl, Vol.34, No.2, pp.371-379, 2011 crossref(new window)

10.
H. S. Sacks and J. N. Fain, "Human epicardial adipose tissue:a review," Am Heart J., Vol.153, No.6, pp.907-917, 2007. crossref(new window)

11.
R. M. Lang, M. Bierig, R. B. Devereux, F. A. Flachskampf, E. Foster, and P. A. Pellikka, et al, "Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology," J Am Soc Echocardiogram, Vol.18, pp.1440-1463, 2005. crossref(new window)

12.
A. H. Kissebah, N. Vydelingum, R. Murray, D. J. Evans, A. J. Hartz, R. K. Kalkhoff, and P. W. Adams, "Relation of body fat distribution to metabolic complications of obesity," J clin Endocrinol Metab, Vol.54, pp.254-260, 1982. crossref(new window)

13.
G. Iacobellis, D. Corradi, and A. M. Sharma, "Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart," Nat Clin. Pract cardiovas Med, Vol.2, pp.536-543, 2005. crossref(new window)

14.
G. Iacobellis, F. Assael, M. C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, and F. Leonetti, "Epicardial fat from echocardiogrphy: a new method for visceral adipose tissue prediction," Obes Res., Vol.11, pp.304-310, 2003. crossref(new window)

15.
Masayoshi Oilkawa and Takashi Owada, Hiroyuki Yamauchi, Tomofumi Misaka, Hirofumi Machii, Takayoshi Yamaki, Koichi Sugimoto, Hiroyuki Kunii, Kazuhiko Nakazato, Hitoshi Suzuki, Shu-ichi Saitoh, and Yasuchika Takeishi, "Epicardial Adipose Tissue Reflects the Presence of Coronary Artery Disease: Comparison with Abdominal Visceral Adipose Tissue," BioMed Research Internation, Vol.2015, pp.1-7, 2015.

16.
G. Iacobellis, M. C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, and F. Leonetti, "Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk," J Clin Endocrinol Metab., Vol.88, pp.5163-5168, 2003. crossref(new window)

17.
T. Mazurek, L. Zhang, A. Zalewski, J. D. Mannion, J. T. Diehl, H. Arafat, L. Sarov-Blat, S. O'Brien, E. A. Keiper, A. G. Johnson, J. Murtin, B. J. Goldstein, and Y. Shi, "Human epicardial adipose tissue is a source of inflammatory medicator," Circulation, Vol.108, pp.2460-2466, 2003. crossref(new window)